Tag Archives: Senate

Calif. Senate OKs prescription drug abuse measures

gavelThe California Senate has given the stamp of approval to a package of bills aimed at reducing prescription drug abuse and overdose deaths, including a measure that would require coroners to report deaths involving prescription drugs to the Medical Board of California. The Los Angeles Times reports that the Senate also signed off on a bill that would upgrade the state’s prescription drug monitoring program, known as CURES. In addition, lawmakers approved a measure that would make it easier for the medical board to investigate physicians suspected of overprescribing and suspend their prescribing privileges, and a bill that would prohibit pharmacies from advertising commonly abused narcotic medications, such as OxyContin and Vicodin, according to the LA Times.

The package of legislation will now move on to the California Assembly for approval.

The CURES bill faced the strongest opposition from the pharmaceutical and biotech industries, the Times says, even though it had the support of a coalition of law enforcement groups, health insurance companies, and business, labor and consumer organizations. That opposition was dropped after the bill’s sponsors removed a provision that called for a tax on drug makers to pay for teams of investigators to crack down on drug-seeking patients and doctors who recklessly prescribe to them, according to the Times.

Posted in Informational, Pharmaceutical Industry, Policy & Regulation | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Pain advocacy group shuts doors amid Senate probe

A U.S. Senate investigation into financial ties between producers of prescription painkillers and organizations that champion such drugs was announced Tuesday, just after the American Pain Foundation, the nation’s largest organization for pain patients, said it would shut down. The group said in a statement on its website that its closure was due to “irreparable economic circumstances.”

APF – which received 90 percent of its $5 million in funding in 2010 from the drug and medical-device industry – came under fire in December over its ties to pharmaceutical companies.

The Senate investigation was launched amid concerns that doctors and consumers aren’t getting accurate information about the risks of powerful opiate painkillers. According to the New York Times, pharmaceutical companies that received notice of the probe include OxyContin maker Purdue Pharma; Endo Pharmaceuticals, which makes Percocet; and Johnson & Johnson, which markets Duragesic.

APF – which was also sent a letter – claims on its website that “misguided state and federal policies are impeding access to appropriate and reasonable medical care for people struggling with pain, and deterring even the most compassionate medical providers from treating anyone with pain conditions.”

Posted in Pain Advocates, Pharmaceutical Industry, Policy & Regulation | Tagged , , , , , , , , , , , , , , , | 3 Comments